2024 INTERNATIONAL MEETING ON ASTHMA, RHINITIS, COPD AND THEIR COMORBIDITIES 2-3 DECEMBER 2024 FIRENZE


MONDAY 2 December 2024

NON ECM SESSION

RIUNIONE DEL GRUPPO DI LAVORO GOLD E MULTIMORBIDITA’

08:30-10:30 ROAD MAP FOR THE MULTIMORBID COPD PATIENT – PART I
Chairmen Antonio Spanevello and Enrico M. Clini

08:30 Alvar Agusti
2025 UPDATE OF THE GOLD REPORT

08:50-10:30 DISCUSSION
Discussants Alvar Agusti, Raffaele F. Antonelli Incalzi, Enrico M. Clini, Angelo Guido Corsico, Francesco Dentali, Claudio Micheletto, Paolo Palange, Alberto Papi

11:00-13:05 ROAD MAP FOR THE MULTIMORBID COPD PATIENT – PART II
Chairmen Raffaele F. Antonelli Incalzi, Lorenzo Corbetta and Francesco Dentali

11:00 Shawn D. Aaron
MANAGEMENT OF EARLY COPD

11:25 Bartolome R. Celli
HOLISTIC APPROACH TO THE MULTIMORBID PATIENT

11:50 Alberto Papi
COPD AND CONCOMITANT CVs DISEASES: RESULTS FROM THE ITALIAN AIFA “ICS LIFE STUDY”

12:15 Christine Jenkins
HOLISTIC APPROACH TO THE MANAGEMENT OF THE MULTIMORBID COPD PATIENT

12:40 Jadwiga Wedzicha
IMAGING AND NATURAL HISTORY OF COPD (FROM RISK TO COMORBIDITIES)


14:00-16:00 COLLABORATION BETWEEN ACADEMIC SCIENTISTS AND PHARMA INDUSTRY SCIENTISTS IN THE DEVELOPMENT OF NOVEL TREATMENTS FOR ASTHMA, ALLERGY/RHINITIS, COPD, MULTIMORBIDITY
Chairmen Matteo Bonini, Leonardo M. Fabbri, Pierluigi Paggiaro, Alberto Papi, Giovanni Passalacqua and Antonio Spanevello

14:00 PATIENTS, PATHWAYS AND PLANET: OUR JOURNEY TO DEFEAT COMPLEX LUNG DISEASES
Diego Ardigò
Executive Vice-President, Head of Global R&D,
Global Research and Development
CHIESI FARMACEUTICI

14:25 A GSK LOOK INTO THE FUTURE OF RESPIRATORY DISEASES
Nadia Kallinikou
European Medical Director,
Respiratory Biologics
GLAXOSMITHKLINE

14:50 IMMUNO-SCIENCE, POWERING SANOFI’S PIPELINE
Asif Khan
Global Medical Immunology Lead,
Respiratory and Gastroenterology
SANOFI

15:15 TRANSFORMING RESPIRATORY HEALTH CARE
Maria Belvisi
SVP and Head of Research and Early Development,
Respiratory & Immunology, BioPharmaceuticals R&D
ASTRAZENECA

15:40 ENSIFENTRINE FOR THE MANAGEMENT OF COPD
Tara Rheault
Chief Development Of!cer,
Head of R&D
VERONA PHARMA

15:50 BEYOND CURRENT LIPID LOWERING THERAPY: THE PROMISE OF CETP INHIBITION
Paolo Fabrizzi
Corporate Medical Affair
and Clinical Operation Director
MENARINI


ECM SESSION

16:00-17:30 COPD DIAGNOSIS AND MANAGEMENT
Chairmen Mauro Maniscalco, Claudio Micheletto and Paolo Palange

16:00 David M.G. Halpin
TIME TO STOP REVERSIBILITY TESTING IN COPD AND ASTHMA

16:20 Alvar Agusti
TREATABLE TRAITS IN THE COPD MULTIMORBID PATIENT

16:40 Fernando J. Martinez
DOES PHARMACOLOGIC TREATMENT INCREASE SURVIVAL IN MULTIMORBID COPD PATIENTS?

17:00 DISCUSSION

18:00-19:00 LECTURE: BIOLOGICS FOR COPD AND ASTHMA
Chairmen Matteo Bonini and Dario Olivieri

18:00 Parameswaran Nair
EOSINOPHILS, CORTICOSTEROIDS AND BIOLOGICS FOR COPD: A COMPLEX INTERPLAY

18:30 Daiana Stolz
ROLE OF BIOMARKERS IN THE MANAGEMENT OF THE MULTIMORBID COPD PATIENT


TUESDAY 3 December 2024


NON ECM SESSION

RIUNIONI DEI GRUPPI DI LAVORO DEI PROGETTI GINA E ARIA

08:00-09:00 GINA (Asthma) ADVOCATE GROUP MEETING
Chairmen Sergio Bonini, Giorgio Walter Canonica, Pierluigi Paggiaro, Fabio Luigi Massimo Ricciardolo and Nicola Alessandro Scichilone

08:00 Celeste M. Porsbjerg
CLINICAL RESPONSE, REMISSION AND PROGNOSIS IN ADULTS WITH SEVERE ASTHMA

08:30 Erik Melén
CLINICAL RESPONSE, REMISSION AND PROGNOSIS IN CHILDREN WITH SEVERE ASTHMA

09:00-11:00 MEETING OF THE ITALIAN GINA-ASTHMA WORKING GROUP: DISCUSSION OF THE 2024 UPDATE OF THE GINA REPORT
Chairman Pierluigi Paggiaro
Discussants Bianca Beghè, Matteo Bonini, Gianenrico Senna and Members of the Working Group

09:30 Helen K. Reddel
DO PATIENT-REPORTED OUTCOMES HAVE A ROLE IN PRECISION MEDICINE FOR RESPIRATORY DISEASE?

09:50-11:00 DISCUSSION

11:30-13:00 ARIA (Rhinitis) GROUP MEETING AND DISCUSSION
Chairmen Giovanni Passalacqua, Carlo Lombardi and Vincenzo Patella

11:30 Giorgio Walter Canonica
ARIA UPDATE

11:50-13:00 DISCUSSION


ECM SESSION

14:00-15:30 PEDIATRIC ASTHMA
Chairpersons Stefania La Grutta, Diego G. Peroni and Francesca Santamaria

14:00 Sejal Saglani
ERS STATEMENT ON PRE-SCHOOL WHEEZING DISORDERS

14:30 Giorgio Piacentini
THE EVOLUTION OF SCIENTIFIC KNOWLEDGE IN CHILDHOOD ASTHMA OVER TIME

15:00 Eugenio Baraldi
NEW INSIGHTS ON THE ROLE OF RESPIRATORY SYNCYTIAL VIRUS INFECTIONS IN CHILDREN

16:00-17:30 PATHOGENESIS OF ASTHMA
Chairpersons Bianca Beghè, Lorenzo Cosmi and Fabio Luigi Massimo Ricciardolo

16:00 Sally E. Wenzel
ASTHMA PATHOGENESIS: PHENOTYPES, THERAPIES AND GAPS: HIGHLIGHTS OF THE ASPEN CONFERENCE

16:30 William W. Busse
UPDATE ON THE NOVEL THERAPEUTIC TARGETS IN ALLERGIC INFLAMMATION

17:00 Klaus F. Rabe
ALARMINS IN THE PATHOGENESIS OF ASTHMA AND COPD

17:30-18:00 FINAL CONCLUSIONS
Leonardo M. Fabbri

18:00-18:15 CME QUESTIONNAIRE AND FAREWELL